Diet, immunity and functional foods

Advances in Experimental Medicine and Biology

Volumn 635, Issue , 2008, Pages 79-92

  Hoyles, Lesley ^a   Vulevic, Jelena ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLON; DIET; DIETARY FIBER; FOOD; HUMAN; IMMUNITY; PHYSIOLOGY; REVIEW;

COLON; DIET; DIETARY FIBER; FOOD; HUMANS; IMMUNITY;

EID: 58149156207     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09550-9_7     Document Type: Article

References (84)

1. Roberfroid MB. Defining functional foods. In: Gibson GR, Williams CM, eds. Functional Foods: Concept to Product. Boca Raton: CRC Press LLC, 2000:9-27.
2. Diplock AT, Agget PJ, Ashwell M et al. Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 1999; 81(suppl):SI-S28.
3. Calder PC, Kew S. The immune system: A target for functional foods? Br J Nutr 2002; 88(suppl): SI65-S176.
4. Calder PC, Field CJ, Gill HS, eds. Nutrition and lmmune Function. Wallingford: CABI Publishing, 2002.
5. Johnson IT. New food components and gastrointestinal health. Proc Nutr Soc 2001; 60:481-485
6. Mollet B, Rowland 1. Functional foods: At the frontier between food and pharrna, Editorial overview. CUrt Opin Biotechnol 2002; 13:483-485. (Pubitemid 35379935)
7. Gibson GR, Roberfroid MB, eds. Colonic Microbiota, Nutrition and Health. Dordrecht: K1uwer Academic Publishers. 1999.
8. Fuller R. Probiotics: growth-promoting factors produced by microorganisms. Science 1989; 147: 747-748.
9. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412.
10. Shortt C. Living it up for dinner. Chern Ind 1998; 8:300-303. (Pubitemid 128442474)
11. Merchnikoff E. The Prolongation of Lite: Optimistic Studies. New York: GP Putnam's Sons, 1908.
12. Molis C, Florie B, Ouarne F et al. Digestion, excretion and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr 1996; 64:324-328. (Pubitemid 26287320)
13. Gibson GR. Probert HM, Loo JV et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17:259-275.
14. Morrow AL, Guerrero ML, Shults J. et al. Efficacyof home-based peer counselling to promote exclusive breastfeeding: A randomised controlled trial. Lancet 1999; 353:1226-1231. (Pubitemid 29168461)
15. Newburg DS, Ruiz-Palacios GM, Morrow AI. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005; 25:37-58. (Pubitemid 41208993)
16. Buddington KK, Donahoo JB, Buddington RK. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J Nutr 2002; 132:472-477. (Pubitemid 34208751)
17. Kelly-Quagliana KA, Nelson PD, Buddingron RK. Dietary oligofructose and inulin modulate immune function in mice. Nutr Res 2003; 23:257-267. (Pubitemid 36369024)
18. Pierre F, Perrin P, Champ M et al. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 1997: 57:225-228. (Pubitemid 27036598)
19. Pierre F, Perrin P, Bassonga E et al. T-cell status influences colon tumor occurrence in Min mice fed short-chain fructo-oligosaccharides as a diet supplement. Carcinogenesis 1999: 20:1953-1956. (Pubitemid 29476122)
20. Hosono A, Ozawa A, Kato R et al. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci Biotechnol Biochem 2003: 67:758-764. (Pubitemid 39251905)
21. Nakamura Y, Nosaka S, Suzuki M et al. Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice. Clin Exp Immunol 2004: 137:52-58. (Pubitemid 38869777)
22. Kudoh K, Shimizu J, Wada M et al. Effect of indigestible saccharides on B-Iymphocyte response of intestinal mucosa and cecal fermentation in rats. J Nutr Sci Vit 1998: 44:103-112. (Pubitemid 28175424)
23. Nagendra R, Venkat Rao S. Effect of feeding infant formulations containing bifidus factors on in vivo proliferation of bifidobacteria and stimulation of intraperitoneal macrophage activity in rats. J Nutr Immunol 1994: 2:61-68. (Pubitemid 24215183)
24. Manhart N, Spittler A, Bergmeister H et al. Influence of fructooligosacchartdes on Peyer's patch lymphocyte numbers in healthy and endotoxemic mice. Nutrition 2003; 19:657-660. (Pubitemid 36794295)
25. Guigoz Y, Rochat F, Perruisseau-Carrier G et al. Effects of oligosaccharide on the faecal flora and nonspecific immune system in elderly people. Nutr Res 2002: 22:13-25. (Pubitemid 34150952)
26. Bunout D, Hirsch S, de la Maza MP et al. Effects of prebiotics on the immune response to vaccination in the elderly. J Parcnter Enter Nutr 2002: 26:372-376. (Pubitemid 35216930)
27. Sazawal S, Dhingra U. Sarkar A et al. Efficacy of milk fortified with a probiotic Bifidobacterium lactis (D R-lOTM) and pre biotic galacto- oligosaccharides in prevention of morbidity and on nutritional status. Asia Pac J Clin Nutr 2004; 13:S28.
28. Gibson GR. Beatty ER, Wang X et al. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108:975-982.
29. Bouhnik Y, Flourie B, D'Agay-bensour L et al. Administration of transgalactooligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997: 127:444-448. (Pubitemid 27119998)
30. Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 2001; 86:291-300. (Pubitemid 32780636)
31. Vulevic J, Rastall RA. Gibson GR. Developing a quantitative approach for determining the in vitro prebioric potential of dietary oligosaccharides. FEMS Microbiol Lett 2004: 236: 153-1 59.
32. Takahashi T, Nakagawa E. Nara T et al. Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci Biotechnol Biochem 1998; 62:10-15. (Pubitemid 128475015)
33. Tejada-Simon MY, Usrunol Z, Pestka JJ. Effects of lactic acid bacteria ingestion of basal cytokine mRNA and immunoglobulin levels in the mouse. J Food Prot 1999: 62:287-291. (Pubitemid 29134026)
34. Qiao H, Duffy LC, Griffiths E et al. Immune responses in rhesus rotavirus-challenged Balb/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res 2002; 51:750-755. (Pubitemid 34547340)
35. Moineau S, Goulet J. Effect of feeding fermented milks on the pulmonary macrophage activity in mice. Milchwissenschafi: 1991: 46:551-554.
36. Matsuzaki T, Yamazaki R, Hashimoto S et al. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 1998: 81:48-53. (Pubitemid 128458515)
37. Tejada-Simon MY, Usrunol Z. Pestka JJ. Ex vivo effects of lactobacilli. streptococci and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J Food Prot 1999: 62: 162-169. (Pubitemid 29101058)
38. Akira S. Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801. (Pubitemid 43261452)
39. Vasselon T, Detmers PA. Toll receptors: A central element in innate immune responses. Infect Immun 2002: 70:1033-1041. (Pubitemid 34163371)
40. Forchielli ML, Walker WA. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 2005: 93(suppl):S41-S48. (Pubitemid 43073406)
41. Hatcher GE, Lambrecht RS. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J Dairy Sci 1993; 76:2485-2492.
42. Macfarlane GT, Cummings JH. The colonic flora, fermentation and large bowel digestive function. In: Phillips SF, Pemberton JH, Shorter RG eds. The Large Intestine: Physiology, Pathophysiology and Disease. New York: Raven Press Ltd. 1991:51-92.
43. Salminen S. Bouley C. Boutron-Ruault MC et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80:S147-S171.
44. Roediger WEW. Utilisation of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982: 83:424-429. (Pubitemid 12078229)
45. Cavaglieri CR, Nishiyama A, Fernandes LC et al. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 2003; 73:1683-1690. (Pubitemid 36859872)
46. Zapolska-Downar D, Siennicka A, Kaczmarczyk Met al. Butyrate inhibits cytokine-induced VCAM-1 and 1CAM-1 expression in cultured endothelial cells: the role ofNF-lCB and PPARu. J Nutr Biochem 2004; 15:220-228. (Pubitemid 38447260)
47. Kruh J, Defer N, Tichonicky L. Effects of butyrate on cell proliferation and gene expression. In: Cummings JH, Rombeau JL, Sakata T, eds, Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge: Cambridge University Press, 1995:275-288.
48. Hague A, Elder DJE, Hicks DJ et al. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995; 60:400-406.
49. Pratt VC, Tappenden KA, McBurney M1 et al. Short-chain fatty acid-supplemented total parenteral nutrition improves nonspecific immunity after intestinal resection in rats. JPEN J Parenter Enteral Nutr 1996; 20:264-271. (Pubitemid 26286190)
50. Ishizaka S, Kikuchi E, Tsujii T. Effects of acetate on human immune system. Immunopharmacol Immunotoxicol 1993; 15:151-162. (Pubitemid 23188510)
51. Wu GY, Field CJ, Marliss EB. Glutamine and glucose metabolism in rat splenocytes and mesenteric lymph node lymphocytes. Am J Physiol1991; 260:E141-EI47.
52. Jenkins DJ, Popovich DG, Kendall CWet al. Metabolic effects of non-absorbable carbohydrates. Scand J Gastroenterol 1999; 222: 10-13. (Pubitemid 27196251)
53. Jenkins DJ, Kendall CW; Vuksan V. Inulin, oligofructose and intestinal function. J Nutr 1999; 129(suppl):1431S-1433S.
54. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. AmJ Clin Nutr 2001; 73(suppl):1131S-1141S. (Pubitemid 32496957)
55. Matsuo K, Ota H, Akamatsu T et al. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997: 40:782-789. (Pubitemid 27305472)
56. Hoskins LC, Boulding ET. Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidasesas extracellular enzymes. J Clin Invest 1981; 67: 163-172. (Pubitemid 11163169)
57. Fontaine N, Meslin JC. Lory S et al. Intestinal mucin distribution in the germ-free rat and in the heteroxenic rat harbouring a human bacterial flora: effect of inulin in the diet. Br J Nutr 1996; 75:881-892. (Pubitemid 26237669)
58. Frankel W; Zhang W; Singh A et al. Fiber: effect on bacterial translocation and intestinal mucin content. World J Surg 1995; 19:144-149.
59. Xu D, Lu Q, Deitch EA. Elemental diet-induced bacterial translocation associated with systemic and intestinal immune suppression. JPEN J Parenter Enteral Nutr 1998; 22:37-41. (Pubitemid 28028587)
60. Shimotoyodome A, Meguro S, Hase T et al. Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp Biochem Physiol A Mol Integr Physiol. 2000; 125:525-531. (Pubitemid 30330771)
61. Finnie IA. Dwarakanath AD, Taylor BA et al. Colonic mucin synthesis is increased by sodium butyrate. Gut 1995; 36:93-99.
62. Gaudier E. Jarry A, Blottiere HM et al. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1l68-G1l74.
63. Barcelo A. Claustre J. Moro F et al. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 2000; 46:218-224 (Pubitemid 30305848)
64. Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996; 347:1017-1021. (Pubitemid 26112177)
65. Boyle EC, Finlay BB. Bacterial pathogenesis: exploiting cellular adherence. Curr Opin Cell Bioi 2003; 15:633-639. (Pubitemid 37176973)
66. Pool-Zobel BL. Lactobacillus and Bifidobacterium mediated antigenotoxicity in the colon of rats. Nutr Cancer 1996; 26:365-380. (Pubitemid 26362074)
67. Rowland IR. Gut microflora and cancer. In: Leeds AR, Rowland IR eds. Gut Flora and Health-Past, Present and Future. London: The Royal Society of Medicine Press Ltd, 1996:19-25. (Pubitemid 126779666)
68. Tzortzis G, Goulas AK, Gee JM et al.A novel galactooligosaccharide mixture increases the bifidobacrerial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents f pigs in vivo. J Nutr 2005; 135:1726-1731. (Pubitemid 40980725)
69. Ross GD. Vetvicka V. CR3 (CDllb. CDI8): A phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 1993; 92: 181-184. (Pubitemid 23151023)
70. Brown GD. Gordon S. Immune recognition. A new receptor for fI-glucans. Nature 2001; 413:36-37. (Pubitemid 32843478)
71. Murosak S, Muroyama K, Yamamoto Y et al. Nigerooligosaccharides augments natural killer activity of hepatic mononuclear cells in mice. Int Immunopharmacol. 2002; 2:151-159. (Pubitemid 33086812)
72. Schley PD. Field CJ. The immune-enhancing effects of dietary fibers and prebiotics. Br J Nutr 2002; 87(suppl):S221-S230. (Pubitemid 34685558)
73. Erickson KL. Medina EA. Hubbard NE. Micronutrients and innate immunity. J Infect Dis 2000; 182:S5-S10.
74. Lopez-Varela S. Gonzalez-Gross M. Marcos A. Functional foods and the immune system: A review. Eur J Clin Nutr 2002; 56(suppl 3):S29-S33.
75. Meydani M. Effect of functional food ingredients: vitamin E modulation of cardiovascular disease and immune status in the elderly.Am J Clin Nutr 2000; 71(suppl):1665S-1668S. (Pubitemid 30396261)
76. Weidermann U. Hanson LA. Bremell T et al. Increased translocation of Escherichia coli and development of arthritis in vitamin A-deficient rats. Infect Immun 1995; 63:3062-3068.
77. Domeneghini C. Di Giancamillo A. Arrighi S et al. Gut-trophic feed additives and their effects upon the gut structure and intestinal metabolism. State of the art in the pig and perspectives towards humans. Histol Histopathol 2006; 21:273-283. (Pubitemid 43033737)
78. Holick ME Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Bioi 2006; doi: 10.1016/j.pbiomolbio.2006.02.014.
79. Froicu M. Zhu Y, Cantorna MT. Vitamin D receptor is required to control gastrointestinal immunity in lL-lO knockout mice. Immunology 2006; 117:310-318.
80. Lin R. White JH. The pleiotropic actions of vitamin D. BioEssays 2003; 26:21-28. (Pubitemid 38095345)
81. YuV. Scientific rationale and benefits of nucleotide supplementation of infant formula. J Paediatr Child Health 2002; 38:543-549 (Pubitemid 35370558)
82. Craig WJ. Health-promoting properties of common herbs. Am J Clin Nutr 1999; 70(suppl): 491S-499S. (Pubitemid 29407127)
83. Borchers AT. Stern JS. Hackman RM et al. Mushrooms. tumors and immunity. Proc Soc Exp Bioi Med 1999; 221:281-293.
84. Broome CS. McArdle F. Kyle JAM et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 2004; 80:154-162. (Pubitemid 41115569)